Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4
Superpotent Drug
- Agency
- FDA Drug
- Recall date
- Aug 21, 2026
- Status
- Ongoing
- Company
- VITRUVIAS THERAPEUTICS INC
1. What product was recalled?
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Quantity: 1955 bottles
Code or lot text: Lot # 504950, Exp Date: 09/30/2026.
- LOT
- Exp Date: 09/30/2026.
- LOT
- Lot # 504950
- NDC
- 69680-165
- NDC
- 69680-165-00
- NDC
- 69680-166
- NDC
- 69680-166-00
- NDC
- 69680-167
- NDC
- 69680-167-00
- NDC
- 69680-168
- NDC
- 69680-168-00
- NDC
- 69680-169
- NDC
- 69680-169-00
- RECALL-NUMBER
- D-0866-2026
2. Is my exact product affected?
Compare every printed identifier. A matching value can indicate that your product is included.
3. What is the hazard?
Superpotent Drug
4. What should I do now?
Follow the FDA recall notice and contact the recalling company for current instructions.
5. Where was it sold or distributed?
Nationwide
6. Were injuries or illnesses reported?
No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.
7. What remedy is available?
Follow the FDA recall notice and contact the recalling company for current instructions.
8. Is the recall active or closed?
The source status is Ongoing. The Recall Guy's urgency label is urgent, which is a separate deterministic site label.
9. When was the information checked?
Last checked .
- created
10. Where is the official source?
Open the official FDA Drug source
The Recall Guy normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.